UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $23
Benzinga Newsdesk 12 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $16.5 to $23.
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $16.5 to $23.